Achieve Life Sciences, Inc. (ACHV) short interest & options flow
NASDAQAchieve Life Sciences heads into its November 6 earnings date with a short book that has barely budged despite a 57% year-to-date rally, two activist 13D filers on the register, and a cytisinicline resubmission expected before year-end. Short interest is the defining feature of this stock right now. At 33.5% of the free float, it is one of the more heavily shorted small-cap…
ACHV utilization surges to 90.5%, highest level in two weeks, as short sellers tighten grip on available shares.
- Market cap
- $692M
- Next earnings
- 13 Nov 2026
Key data as of 8 Nov 2026
Latest signals on ACHV
- Utilization
ACHV utilization surges to 90.5%, highest level in two weeks, as short sellers tighten grip on available shares.
ACHV news and analysis
RSSNo long-form analysis yet for ACHV. Pulse alerts and the live data picture are available on ORTEX.
Open ACHV on ORTEX →Want the live picture for ACHV?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ACHV — free to start on ORTEX.
Sign up for free →Open ACHV on ORTEX